Quest Diagnostics vs Veracyte: revenue, profit, margins and growth compared
Quest Diagnostics brought in $11B of revenue in fiscal 2025, Veracyte $517.1M in fiscal 2025. Revenue changed by +11.8% at Quest Diagnostics and +16.0% at Veracyte on the year before, so Veracyte grew faster. Quest Diagnostics kept 9.0% of its revenue as net profit, Veracyte 12.8%. Free cash flow was $1.4B at Quest Diagnostics and $126.6M at Veracyte.
Fiscal years as each company reports them; the two may end in different months.
Questions about Quest Diagnostics and Veracyte
Which is bigger by revenue, Quest Diagnostics or Veracyte?
Quest Diagnostics is bigger by revenue: $11B in fiscal 2025, against $517.1M for Veracyte in fiscal 2025.
Which keeps more of its revenue as profit, Quest Diagnostics or Veracyte?
Quest Diagnostics had a net margin of 9.0% in fiscal 2025; Veracyte had 12.8% in fiscal 2025.
Which grew revenue faster, Quest Diagnostics or Veracyte?
In their latest fiscal years revenue changed by +11.8% at Quest Diagnostics and +16.0% at Veracyte.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.